FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor

Published Date: 27 May 2025

A study led by researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and the Broad Institute of MIT and Harvard has uncovered critical insights into the biology of embryonal tumor with multilayered ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GuCS: Genitourinary Cancers Symposium

2.

In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".

3.

Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors

4.

Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat

5.

FDA Approves Subcutaneous Isatuximab for MM Indications


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot